![]() To learn more, please join the Wilson Center on Thursday, September 29, 2022, 10:00 am to 11:00 am ET for a dialogue on Phase Two of “vaccine diplomacy. and European producers of highly effective mRNA vaccines invest more in overseas production? What are the public health and geopolitical implications of Chinese and Russian vaccine production in the developing world? What is the status of European Union and World Health Organization efforts to build vaccine development and production capabilities in Latin America and other developing regions? What are the strengths and barriers in countries such as Argentina, Brazil and Mexico? In Latin America, for example, Argentina is already producing Russia’s Sputnik vaccine and Chile plans to manufacture China’s Sinovac jabs. That transition would reduce the likelihood of shortages in the near future and in any future pandemic, and provide economic benefits to developing economies. However, the EU will not extend the COVID-19 vaccines export transparency and authorisation mechanism, which expires on 31 December 2021. Later, it opened opportunities for countries such as China and Russia, and later the United States, to improve diplomatic relationships through the sale and donation of shots, a strategy sometimes referred to as “vaccine diplomacy.”Īs the pandemic persists, and waning immunity and new viral variants increase the importance of booster shots, many governments are emphasizing the importance of transitioning to a new phase of “vaccine diplomacy”: a global expansion of vaccine development and production capabilities. Initially, that dependency delayed vaccine campaigns, with significant public health consequences. ![]() Throughout the pandemic, regions such as Latin America have been almost entirely dependent on imported COVID-19 vaccines.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |